<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">100962781</journal-id>
<journal-id journal-id-type="pubmed-jr-id">22270</journal-id>
<journal-id journal-id-type="nlm-ta">Nat Rev Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat. Rev. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="ppub">1471-003X</issn>
<issn pub-type="epub">1471-0048</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30206328</article-id>
<article-id pub-id-type="pmc">7255106</article-id>
<article-id pub-id-type="doi">10.1038/s41583-018-0057-5</article-id>
<article-id pub-id-type="manuscript">NIHMS1588727</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Microglial signatures and their role in health and disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Butovsky</surname>
<given-names>Oleg</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weiner</surname>
<given-names>Howard L.</given-names>
</name>
<xref ref-type="corresp" rid="CR1">*</xref>
</contrib>
<aff id="A1">Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA</aff>
</contrib-group>
<author-notes>
<fn fn-type="con" id="FN1">
<p id="P1">Author contributions</p>
<p id="P2">O.B. and H.L.W. researched data for the article, made substantial contributions to the discussion of content, wrote the article and reviewed and/or edited the manuscript before submission.</p>
</fn>
<corresp id="CR1"><label>*</label><email>obutovsky@rics.bwh.harvard.edu</email>; <email>hweiner@rics.bwh.harvard.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P67">Competing interests</p>
<p id="P68">O.B. and H.L.W. hold patent applications entitled ‘Targeting Apolipoprotein E (APOE) in Neurologic Disease’ (PCT/US2015/056492), ‘Micrornas in Neurodegenerative Disorders’ (PCT/US2012/059671) and ‘Mir-155 Inhibitors for Treating Amyotrophic Lateral Sclerosis (ALS)’ (Application #20180161357), which have exclusive licensing rights from the Brigham and Women’s Hospital. O.B. is an adviser and collaborator for Sanofi and Nanostring.</p>
<p id="P69">Publisher’s note</p>
<p id="P70">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
<p id="P71">Reviewer information</p>
<p id="P72"><italic>Nature Reviews Neuroscience</italic> thanks B. Eggen, M. Prinz and M.-E. Tremblay for their contribution to the peer review of this work.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>6</day>
<month>5</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="ppub">
<month>10</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>28</day>
<month>5</month>
<year>2020</year>
</pub-date>
<volume>19</volume>
<issue>10</issue>
<fpage>622</fpage>
<lpage>635</lpage>
<!--elocation-id from pubmed: 10.1038/s41583-018-0057-5-->
<abstract id="ABS1">
<p id="P3">Microglia are the primary innate immune cells in the CNS. In the healthy brain, they exhibit a unique molecular homeostatic ‘signature’, consisting of a specific transcriptional profile and surface protein expression pattern, which differs from that of tissue macrophages. In recent years, there have been a number of important advances in our understanding of the molecular signatures of homeostatic microglia and disease-associated microglia that have provided insight into how these cells are regulated in health and disease and how they contribute to the maintenance of the neural environment.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>